Doctors Note Logo

Published on: 1/30/2026

Farxiga Uses: Diabetes, Heart Failure, and Kidney Disease (Explained)

Farxiga treats type 2 diabetes, heart failure with reduced or preserved ejection fraction, and chronic kidney disease, including in many people without diabetes. It is an SGLT2 inhibitor that helps the kidneys excrete extra sugar and fluid, which improves blood sugar, modestly reduces weight and blood pressure, lowers heart failure hospitalizations and cardiovascular death, and slows CKD progression and the need for dialysis. There are several factors to consider, including who should avoid it and safety issues like genital or urinary infections, dehydration, and rare ketoacidosis, as well as how and when to take it; see the important details below to guide your next steps.

answer background

Explanation

Farxiga Uses: Diabetes, Heart Failure, and Kidney Disease (Explained)

Farxiga (generic name: dapagliflozin) is a prescription medication that has become an important treatment option for several chronic conditions. Originally approved for type 2 diabetes, Farxiga is now also used to help manage heart failure and chronic kidney disease (CKD)—even in some people who do not have diabetes.

This guide explains how Farxiga works, what it is used for, who may benefit, and what to know about safety—using clear, everyday language and information based on well-established medical research and regulatory guidance.


What Is Farxiga?

Farxiga belongs to a class of medicines called SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors).

How Farxiga Works (In Simple Terms)

  • Your kidneys normally filter sugar from the blood and send it back into the body.
  • Farxiga blocks part of this process.
  • As a result, extra sugar leaves the body through urine.
  • This also causes mild fluid and salt loss, which helps reduce stress on the heart and kidneys.

Because of these effects, Farxiga does more than just lower blood sugar.


Farxiga Uses at a Glance

Farxiga is commonly prescribed for:

  • Type 2 diabetes
  • Heart failure (with reduced or preserved ejection fraction)
  • Chronic kidney disease

Each use is explained in more detail below.


Farxiga for Type 2 Diabetes

How It Helps

For people with type 2 diabetes, Farxiga helps lower blood sugar levels by removing excess glucose through urine. It works independently of insulin, which makes it useful at many stages of diabetes.

Key Benefits

  • Lowers A1C (average blood sugar over time)
  • May lead to modest weight loss
  • Low risk of low blood sugar when used alone
  • Can be combined with other diabetes medications, including insulin

Who May Benefit Most

  • Adults with type 2 diabetes who need better glucose control
  • People with diabetes who also have heart or kidney disease

Farxiga is not approved for type 1 diabetes and should not be used for diabetic ketoacidosis.


Farxiga and Heart Failure

One of the most important newer uses of Farxiga is in heart failure, even for people without diabetes.

What the Research Shows

Large clinical trials have shown that Farxiga can:

  • Reduce the risk of hospitalization for heart failure
  • Lower the risk of cardiovascular death
  • Improve symptoms like shortness of breath and fatigue

Types of Heart Failure Treated

Farxiga is approved for:

  • Heart failure with reduced ejection fraction (HFrEF)
  • Heart failure with preserved ejection fraction (HFpEF)

Why It Helps the Heart

Farxiga:

  • Reduces fluid buildup
  • Lowers pressure inside the heart
  • Improves energy use in heart cells
  • Decreases strain on the cardiovascular system

These benefits are seen whether or not a person has diabetes.


Farxiga for Chronic Kidney Disease (CKD)

Farxiga is also approved to slow the progression of chronic kidney disease.

How It Protects the Kidneys

  • Reduces pressure inside the kidney’s filtering units
  • Lowers protein loss in urine
  • Slows long-term decline in kidney function

Who May Benefit

  • Adults with CKD stages 2–4
  • People with or without type 2 diabetes
  • Patients at risk of kidney failure or dialysis

Studies have shown Farxiga can significantly reduce the risk of:

  • Kidney failure
  • Need for dialysis or transplant
  • Death from kidney or heart-related causes

Possible Side Effects of Farxiga

Most people tolerate Farxiga well, but side effects can happen.

Common Side Effects

  • Increased urination
  • Genital yeast infections
  • Urinary tract infections
  • Mild dehydration
  • Dizziness, especially when standing

Less Common but Serious Risks

  • Ketoacidosis (even with normal blood sugar)
  • Severe dehydration
  • Kidney function changes
  • Rare genital infections (such as Fournier’s gangrene)

These risks are uncommon but important to recognize early.


Who Should Be Careful or Avoid Farxiga?

Farxiga may not be appropriate for everyone.

Use Caution If You:

  • Have severe kidney failure or are on dialysis
  • Have frequent urinary or genital infections
  • Are prone to dehydration
  • Are following a very low-carb or ketogenic diet

Tell Your Doctor If You:

  • Feel very thirsty all the time
  • Urinate excessively
  • Have unexplained fatigue or weakness

Some of these symptoms can overlap with other conditions. You may want to consider doing a free, online symptom check for Diabetes Insipidus to better understand what might be going on.


How Farxiga Is Taken

  • Usually taken once daily
  • Can be taken with or without food
  • Dose is based on condition and kidney function

Your doctor may adjust the dose or stop the medication temporarily during:

  • Severe illness
  • Surgery
  • Prolonged fasting
  • Dehydration

Important Safety Tips

  • Drink enough fluids, especially in hot weather
  • Maintain good genital hygiene
  • Monitor blood sugar if you have diabetes
  • Report unusual symptoms promptly

Do not stop Farxiga suddenly without medical advice, especially if you are taking it for heart failure or kidney disease.


Frequently Asked Questions About Farxiga

Does Farxiga cause weight loss?

Many people experience modest weight loss due to sugar and fluid loss, but it is not a weight-loss drug.

Does Farxiga lower blood pressure?

Yes, slightly. This can be helpful but may cause dizziness in some people.

Can Farxiga be used without diabetes?

Yes. It is approved for heart failure and chronic kidney disease in people without diabetes.

Is Farxiga a cure?

No. Farxiga helps manage chronic conditions and reduce risks, but it does not cure diabetes, heart failure, or kidney disease.


The Bottom Line on Farxiga

Farxiga is a versatile medication with proven benefits for:

  • Type 2 diabetes
  • Heart failure
  • Chronic kidney disease

It works by helping the body remove excess sugar and fluid through the kidneys, reducing stress on vital organs. For many people, it can improve quality of life and lower the risk of serious complications.

That said, Farxiga is not right for everyone. Side effects and risks—while uncommon—can be serious if ignored.

Always speak to a doctor about:

  • New or worsening symptoms
  • Signs of dehydration, infection, or severe fatigue
  • Any condition that could be life-threatening or serious

A healthcare professional can help determine whether Farxiga is appropriate for you and how to use it safely as part of a complete treatment plan.

(References)

  • * McCormack PL. Dapagliflozin: A Review in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease. Drugs. 2022 Mar;82(4):469-484. PMID: 35147989.

  • * Rathi C, Jaiswal V, Gupta V, et al. Dapagliflozin: A SGLT2 Inhibitor with Pleiotropic Effects on Diabetes, Heart Failure, and Chronic Kidney Disease. Pharmaceuticals (Basel). 2022 Mar 29;15(4):418. PMID: 35402633.

  • * McMurray JJV, Solomon SD, Inzucchi SE, et al.; DAPA-HF Committees and Investigators. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019 Nov 21;381(21):1995-2008. PMID: 31535829.

  • * Wiviott SD, Raz I, Bonaca MP, et al.; DECLARE-TIMI 58 Investigators. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019 Jan 24;380(4):347-357. PMID: 30427852.

  • * Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al.; DAPA-CKD Trial Committees and Investigators. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020 Oct 8;383(15):1436-1446. PMID: 32971150.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Diabetes Insipidus

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.